Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qiagen NV

46.55
0.0000
Post-market: 46.550.00000.00%16:19 EDT
Volume:870.34K
Turnover:40.54M
Market Cap:10.08B
PE:110.70
High:46.81
Open:46.50
Low:46.25
Close:46.55
Loading ...

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Simply Wall St.
·
29 Mar

HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?

Zacks
·
19 Mar

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

Zacks
·
08 Mar

QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel

Zacks
·
07 Mar

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
06 Mar

Qiagen announces FDA clearance for QIAstat-Dx Gastrointestinal Panel 2 Mini B

TIPRANKS
·
06 Mar

QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel

MT Newswires Live
·
06 Mar

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

Business Wire
·
06 Mar

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey
·
04 Mar

Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux

MT Newswires Live
·
03 Mar

Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property

Reuters
·
03 Mar

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

Business Wire
·
03 Mar

Hologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?

Zacks
·
26 Feb

Qiagen price target lowered to EUR 48 from EUR 54.90 at Berenberg

TIPRANKS
·
25 Feb

Qiagen Cut to Neutral From Outperform by Baird

Dow Jones
·
19 Feb

Qiagen downgraded to Neutral from Outperform at Baird

TIPRANKS
·
19 Feb

Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses

Simply Wall St.
·
14 Feb

Qiagen Strengthens Global Bioinformatics Leadership With New Data Center In Australia/Asia-Pacific Region

Reuters
·
14 Feb

QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region

Business Wire
·
14 Feb

Kepler Capital Reaffirms Their Hold Rating on Qiagen (QGEN)

TIPRANKS
·
11 Feb